NCT06334133Phase 3Active not recruiting

Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

Study sponsor: vTv Therapeutics

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2027-04Estimated
Enrollment · participants150Estimated
Source updated2026-07-28Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 2 fields changed

Primary completion date changed

− Before

Sep 2026

+ After

Apr 2027

Recruitment status changed

− Before

Recruiting

+ After

Active not recruiting

Check registry source